LivaNova CARES
LivaNova Cares has an expanded mission which includes support for both epilepsy and heart disease awareness. Through fundraising efforts and partnerships with the Epilepsy Foundation of Texas and the national Epilepsy Foundation, LivaNova Cares currently supports numerous efforts targeted towards people and families affected by epilepsy. We are currently looking for cardiac-related organizations to support to further our mission to improve awareness for heart disease.
ICO
461199316
0
X (Twitter)
12
Address
Houston
From Social media
News about from their social media (Facebook and X).
Data about organisation
Houston
Organisations from LivaNova CARES
1711. Advancing Women in Cybersecurity
Diversifying Cyber; One Woman at a Time.
Interesting nearby
Interesting organisations close by to residence of LivaNova CARES
Inspire · Educate · Research.
Krist Samaritan Counseling Center
Krist Samaritan Center is a non-profit organization that provides mental health care to all.
Similar social media (12)
Organisations with similar social media impact to LivaNova CARES
Similar social media
Join us and make a difference for the future!
Eduo connects you to causes that actually matter to you.
Eve
Eduo is where compassion meets clarity.
Michelle
A brilliant resource for anyone who wants to do good more effectively.
Joanna
Clean, community-driven, and full of heart — love it.
Eve
Eduo is where compassion meets clarity.
Lucy
Great for discovering hidden-gem organizations near me.
Daniel
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News
Daniela
2025-10-23
🌍 Exciting news from Uganda! Catholic Relief Services is looking for a Project Officer in Monitoring, Evaluation, Accountability, and Learning to join their team. This is a fantastic opportunity to contribute to meaningful change in communities! 💪🙌 #GoodNews #ProSocialImpact
Project Officer - Monitoring, Evaluation, Accountability, and Learning - Uganda
ReliefWeb
Like Comment
Matuš
2025-10-23
Exciting news! 🎉 ADARx Pharmaceuticals has just dosed the first participant in a Phase III trial for ADX-324, a promising treatment for hereditary angioedema! This innovative therapy shows great potential in improving lives. Let’s celebrate advancements in healthcare! #GoodNews #HealthcareInnovation
ADARx doses first subject in Phase III trial of ADX-324 for HAE
Yahoo
Like Comment
